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Viral exacerbations in patients with COPD can accentuate
disease severity by increasing lung inflammation and
decreasing lung function. Using a synthetic analog of dou-
ble stranded RNA (Poly I:C ) in combination with cigarette
smoke, we have found synergistic increases in total lung
inflammation as well as other tissue biomarkers compared
to Poly I:C alone. Female C57 BL/6 mice were exposed to
room air or the smoke of 3R4F Kentucky Reference cigar-
ettes twice daily for two weeks. On days 0, 3 and 7 animals
were dosed with intranasal PBS or 50 ug of Poly I:C. On
day 11 we observed significant increases in total inflamma-
tion, absolute macrophages and absolute neutrophils in
animals receiving smoke+Poly I:C compared to Poly I:C
alone. There was also a trend showing increased absolute
lymphocyte counts with increases observed in both CD4+
and CD8+ T cells in animals receiving Poly I:C alone or in
combination with smoke. Gene expression from whole
lungs showed synergistic increases in the TH17 cytokines,
IL-21, IL-22 compared to Poly I:C alone. In addition,
increases in the expression of elastin in lung tissue may
indicate the beginning of tissue damage which could
potentially lead to increased alveolar space with longer
exposure to smoke. This model of viral exacerbation has
robust, reproducible inflammation, with an inflammatory
cell influx that resembles inflammation in human COPD
and has the potential to identify novel protein and gene
expression biomarkers.
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